Trixeo Aerosphere

COPD triple therapy! AstraZeneca Trixeo Aerosphere was approved in the European Union, and China has been listed!

AstraZeneca recently announced that the European Commission (EC) has approved Trixeo Aerosphere (Chinese trade name: Becerui® Lingchang®,budesonide/glycopyrrolate/formoterol fumarate, budigo Fu inhaled aerosol) is used for the maintenance treatment of adult patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Head and neck cancer

Head and neck cancer ushered in a new breakthrough in treatment not seen in ten years

On December 11, the official website of China National Medical Products Administration (NMPA) showed that Merck’s PD-1 inhibitor pembrolizumab (trade name: Kerida) was approved as a single drug for the evaluation of tumors through fully validated tests First-line treatment for patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC) expressing PD-L1 (comprehensive positive score (CPS) ≥ 20), becoming the first immune first-line treatment for head and neck squamous cell carcinoma in China .

Science:Significant progress! Inhibition of 15-PGDH protein can rejuvenate the muscles of old mice

In a new study, researchers from the Stanford University School of Medicine found that inserting a protein active for one month in old mice can restore their atrophic muscle mass and strength, and help them correlate on a treadmill The results of the study were published online in the journal Science on December 10, 2010, with the title of the paper .

[Invitation by the Medical Insurance Chamber of Commerce] 2020 Epidemic Prevention Materials Boutique Exhibition invites you to come and join in the grand event! ——Enclosed is the procurement guide for epidemic prevention materials

The new crown pneumonia epidemic that has spread to the world has brought unprecedented challenges to global public health security, and has profoundly affected the development pattern of the global pharmaceutical and health industry.
Human Growth Hormone

New medicine for growth hormone deficiency in children!

September 5, 2020/Bio Valley BIOON/ --The Danish biopharmaceutical company Ascendis Pharma recently announced that the US Food and Drug Administration (FDA) has accepted a weekly long-acting growth hormone TransCon hGH (lonapegsomatropin) biological product license Application (BLA), the drug is a long-acting prodrug of human growth hormone (hGH)administered once a week for the treatment of growth hormone deficiency (GHD) in children.


Melanotan-II is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months.
Name: Melanotan-II; CAS#: 121062-08-6
Understanding the Beneficial Effects of Pentadecapeptide BPC 157

Understanding the Beneficial Effects of Pentadecapeptide BPC 157

Perhaps you can recall from your days of high school biology when the teacher briefly went over the importance of amino acids.
Though the lesson that day could have expanded into a full-fledged college course, the final message was simple: amino acids are the building blocks of life on Earth.

Energy,vitality and strength peptide BPC-157

Consisting of just 15 amino acids, the synthetic peptide BPC-157 offers various healing and regenerative properties.
The partial sequence of this body protection compound isn’t found naturally in the body, nor are there natural biological processes that produce it.
Instead, it has been derived from proteins found in digestive juices.

What Should Tested Athletes Know About GW1516?

GW1516 is known by many names, including cardarine and endurobol, as well as various iterations of the initials and numbers (e.g., GW501516). Often advertised as a selective androgen receptor modulator (SARM), GW1516 is actually a peroxisome proliferated-activated receptor d (PPARd ) agonist and is prohibited under S4.5 Metabolic Modulators on the World Anti-Doping Agency (WADA) Prohibited List.
Substances in this category modify how the body metabolizes fat and GW1516 was originally synthesized and evaluated for the treatment of obesity, diabetes, and other disorders caused by metabolic problems.